Medicinal plants today form a major portion of rich biodiversity globally and are still not explored to its potential. The need for the new medicinal products out from the plant has received a great interest in the present research world due to high cost and the higher side effects that are associated with the chemically manufactured drug.
Catharanthine is defined as an alkaloid which is isolated from catharanthus roseus, which is a potent medicinal plant for many of the pharmacological reactions such as antimicrobial, antioxidant and antidiabetic effect amongst others. The essential chemical, can be used as a starting material for the synthesis of the anti-tumour drugs vinblastine and vincristine.
It stimulates the release of amylase from pancreatic fragments and causes extensive degranulation of pancreatic acinar cells. Catharanthine finds a number of application in the healthcare and pharmaceutical industry. It is highly utilized in the treatment of childhood cancer.
Catharanthine is less known in the market and hence is at the initial stage of advancement showcasing high potential over the forecast period. Catharanthine is relatively new to the market and hence, the global catharanthine market is very niche. Moreover, with the increasing awareness among market players about the benefits of catharanthine, the market is anticipated to witness a high growth over the forecast period.
The catharanthine market is expected to be worth US$ 817.73 million in 2022. The catharanthine market is expected to reach US$ 1164.68 million by 2032, growing at a CAGR of 3.6% between 2022 and 2032.
Catharanthine is less well-known in the catharanthine market and, thus, in its early stages of development, exhibiting high potential over the forecast period. Catharanthine is a new product on the market, so the global catharanthine market is small. Furthermore, with increasing awareness among market participants about the benefits of catharanthine, the catharanthine market is expected to grow rapidly over the forecast period.
The growth of the medical and pharmaceutical industries is primarily driving the global catharanthine market. Global healthcare expenditure currently accounts for 10.6% of total GDP and is expected to grow at a steady CAGR of 5% over the next five years. Catharanthine is widely used in the healthcare industry.
Rising chronic disease patients, such as cancer and tumours, increase the demand for catharanthine-based drugs. Government initiatives and a wide range of policies are expected to accelerate the growth of the catharanthine market during the forecast period.
The rise in chronic diseases has increased demand for pharmaceutical products, which is expected to drive the global catharanthine market by the end of the forecast period. Other macroeconomic factors influencing the global catharanthine market include an ageing population, changing lifestyles, and an increase in disposable income.
| Attributes | Details |
|---|---|
| Catharanthine Market CAGR | 3.6% |
| Catharanthine Market Size 2022 | US$ 817.73 million |
| Catharanthine Market Size 2032 | US$ 1164.68 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Catharanthine sulphate held the largest share of the catharanthine market and is expected to grow at a CAGR of 4.4% between 2022 and 2032. Catharanthine sulphate is an antitumor alkaloid precursor of the vinblastine type.
It works by blocking ion channels and desensitising the AChR (Acetylcholine Receptor). It is a natural alkaloid that disrupts the formation of microtubule structures, causing cell apoptosis. The catharanthine market is expected to grow during the forecast period due to the importance of Catharine sulphate and Catharanthine tartrate.
The pharmaceutical segment held the largest share of the catharanthine market and is expected to grow at a CAGR of 7.6% between 2022 and 2027. The most important indole alkaloids, VLB (Vinblastine) and VCR (Vincristine) are anticancer agents in clinical trials.
Vinblastine is an active agent in the treatment of breast cancer and is used to treat non-Hodgkin lymphoma. Vincristine is a paediatric chemotherapeutic agent that is used to treat both hematologic malignancies and solid tumours. The increasing number of cancer cases and deaths around the world boosts demand for the catharanthine market during the forecast period.
The global catharanthine market is expected to expand as a result of technological advancements made by the majority of global manufacturers. In the coming years, more and more players are expected to invest in catharanthine production.
The catharanthine market is concentrated in North America and is expected to contribute the greatest market share due to North America's dominance in the global pharmaceutical industry. This is usually due to the prominence of the US pharmaceutical industry.
In the global catharanthine market, Asia Pacific is expected to grow at the fastest rate. This is primarily due to the expanding pharmaceutical industry in emerging markets like India and China. The European countries are also expected to play a significant role in the global catharanthine market.
The global catharanthine market is mainly driven by the growth in the medical and pharmaceutical industry. Currently, the global healthcare expenditure represents 10.6% of the overall GDP and is anticipated to register a steady CAGR of 5% in the next five years. Catharanthine finds major application in healthcare industry.
The rise in chronic diseases has led to the increase in the demand for pharmaceutical products, which in turn is projected to boost the global catharanthine market by the end of forecast period. Moreover, some of the other macro-economic factors affecting the global catharanthine market are aging population, changing lifestyle of people and the increase in disposable income of people.
The global catharanthine market is anticipated to grow with the technological advancements undertaken by most of the global manufacturers. More and more players are expected to invest in the catharanthine production in the coming years.
Principal Consultant
In terms of geography, the global catharanthine market has been divided in to seven key regions including North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Middle East & Africa and Japan. The catharanthine market is concentrated in North America region and is expected to contribute maximum market share as North America contributes maximum share in the global pharmaceutical industry.
This is typically due to the prominent role of US pharmaceutical sector. Asia Pacific is also expected to demonstrate highest growth rate in the global catharanthine market. This is basically due to the growing pharmaceutical industry in emerging economies such as India and China. The European countries are also expected to contribute a prominent share in the global catharanthine market.
Key players in the global catharanthine market include AK Scientific Inc, Stanford Chemicals, Cayman Chemicals, Bio Vision Inc, Enzo Biochem Inc, Hainan Yueyang Biotech Co Ltd, Abcam and ChemFaces.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, product type and end use.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Analysis and Forecast 6.1. Product Type 6.2. End Use Industry 7. Global Analysis and Forecast, By Product Type 7.1. Catharanthine Sulfate 7.2. Catharanthine Tartrate 8. Global Analysis and Forecast, By End Use Industry 8.1. Food & Beverage 8.2. Pharmaceutical 9. Global Analysis and Forecast, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. Asia Pacific 9.6. Japan 9.7. Middle East & Africa 10. North America Sales Analysis and Forecast, by Key Segments and Countries 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries 15. Japan Sales Analysis and Forecast, by Key Segments and Countries 16. Middle East & Africa Sales Analysis and Forecast, by Key Segments and Countries 17. Sales Forecast by Product Type and End Use Industry for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. AK Scientific Inc 19.2. Stanford Chemicals 19.3. Cayman Chemicals 19.4. Bio Vision Inc 19.5. Enzo Biochem Inc 19.6. Hainan Yueyang Biotech Co Ltd 19.7. Abcam 19.8. ChemFaces
Explore Chemicals & Materials Insights
View Reports
Catharanthine Market
